Rossari Biotech jumps on reporting 19% rise in Q1 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Rossari Biotech is currently trading at Rs. 816.05, up by 17.45 points or 2.19% from its previous closing of Rs. 798.60 on the BSE.
The scrip opened at Rs. 839.90 and has touched a high and low of Rs. 839.90 and Rs. 795.10 respectively. So far 6972 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 895.00 on 25-Jul-2023 and a 52 week low of Rs. 657.80 on 05-Jun-2024.
Last one week high and low of the scrip stood at Rs. 839.90 and Rs. 790.50 respectively. The current market cap of the company is Rs. 4517.44 crore.
The promoters holding in the company stood at 68.32%, while Institutions and Non-Institutions held 21.78% and 9.90% respectively.
Rossari Biotech has reported 12.85% rise in its net profit at Rs 24.33 crore for first quarter ended June 30, 2024 (Q1FY25) as compared to Rs 21.56 crore for the same quarter in the previous year. Total income of the company increased by 16.28% at Rs 301.97 crore for Q1FY25 as compared to Rs 259.68 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 19.43% rise in net profit at Rs 34.90 crore for Q1FY25 as compared to Rs 29.22 crore for the same quarter in the previous year. Total income of the company increased by 18.84% at Rs 490.60 crore for Q1FY25 as compared to Rs 412.80 crore for the corresponding quarter previous year.
